145 related articles for article (PubMed ID: 37933890)
1. A Machine Learning-Based Unenhanced Radiomics Approach to Distinguishing Between Benign and Malignant Breast Lesions Using T2-Weighted and Diffusion-Weighted MRI.
Liu Y; Jia X; Zhao J; Peng Y; Yao X; Hu X; Cui J; Chen H; Chen X; Wu J; Hong N; Wang S; Wang Y
J Magn Reson Imaging; 2023 Nov; ():. PubMed ID: 37933890
[TBL] [Abstract][Full Text] [Related]
2. Radiomics Based on Multimodal MRI for the Differential Diagnosis of Benign and Malignant Breast Lesions.
Zhang Q; Peng Y; Liu W; Bai J; Zheng J; Yang X; Zhou L
J Magn Reson Imaging; 2020 Aug; 52(2):596-607. PubMed ID: 32061014
[TBL] [Abstract][Full Text] [Related]
3. Prediction of malignancy by a radiomic signature from contrast agent-free diffusion MRI in suspicious breast lesions found on screening mammography.
Bickelhaupt S; Paech D; Kickingereder P; Steudle F; Lederer W; Daniel H; Götz M; Gählert N; Tichy D; Wiesenfarth M; Laun FB; Maier-Hein KH; Schlemmer HP; Bonekamp D
J Magn Reson Imaging; 2017 Aug; 46(2):604-616. PubMed ID: 28152264
[TBL] [Abstract][Full Text] [Related]
4. Differentiating Benign from Malignant Renal Tumors Using T2- and Diffusion-Weighted Images: A Comparison of Deep Learning and Radiomics Models Versus Assessment from Radiologists.
Xu Q; Zhu Q; Liu H; Chang L; Duan S; Dou W; Li S; Ye J
J Magn Reson Imaging; 2022 Apr; 55(4):1251-1259. PubMed ID: 34462986
[TBL] [Abstract][Full Text] [Related]
5. Clinical Breast MRI-based Radiomics for Distinguishing Benign and Malignant Lesions: An Analysis of Sequences and Enhanced Phases.
Wang G; Guo Q; Shi D; Zhai H; Luo W; Zhang H; Ren Z; Yan G; Ren K
J Magn Reson Imaging; 2023 Nov; ():. PubMed ID: 38006286
[TBL] [Abstract][Full Text] [Related]
6. Prediction of High-Risk Cytogenetic Status in Multiple Myeloma Based on Magnetic Resonance Imaging: Utility of Radiomics and Comparison of Machine Learning Methods.
Liu J; Zeng P; Guo W; Wang C; Geng Y; Lang N; Yuan H
J Magn Reson Imaging; 2021 Oct; 54(4):1303-1311. PubMed ID: 33979466
[TBL] [Abstract][Full Text] [Related]
7. Bi-parametric magnetic resonance imaging based radiomics for the identification of benign and malignant prostate lesions: cross-vendor validation.
Ji X; Zhang J; Shi W; He D; Bao J; Wei X; Huang Y; Liu Y; Chen JC; Gao X; Tang Y; Xia W
Phys Eng Sci Med; 2021 Sep; 44(3):745-754. PubMed ID: 34075559
[TBL] [Abstract][Full Text] [Related]
8. Association of Pathological Features and Multiparametric MRI-Based Radiomics With TP53-Mutated Prostate Cancer.
Chen R; Zhou B; Liu W; Gan H; Liu X; Zhou L
J Magn Reson Imaging; 2023 Dec; ():. PubMed ID: 38153859
[TBL] [Abstract][Full Text] [Related]
9. MRI-Based Machine Learning for Differentiating Borderline From Malignant Epithelial Ovarian Tumors: A Multicenter Study.
Li Y; Jian J; Pickhardt PJ; Ma F; Xia W; Li H; Zhang R; Zhao S; Cai S; Zhao X; Zhang J; Zhang G; Jiang J; Zhang Y; Wang K; Lin G; Feng F; Lu J; Deng L; Wu X; Qiang J; Gao X
J Magn Reson Imaging; 2020 Sep; 52(3):897-904. PubMed ID: 32045064
[TBL] [Abstract][Full Text] [Related]
10. TP53 Mutation Estimation Based on MRI Radiomics Analysis for Breast Cancer.
Sun K; Zhu H; Chai W; Yan F
J Magn Reson Imaging; 2023 Apr; 57(4):1095-1103. PubMed ID: 35771720
[TBL] [Abstract][Full Text] [Related]
11. Radiomics-based machine learning analysis and characterization of breast lesions with multiparametric diffusion-weighted MR.
Sun K; Jiao Z; Zhu H; Chai W; Yan X; Fu C; Cheng JZ; Yan F; Shen D
J Transl Med; 2021 Oct; 19(1):443. PubMed ID: 34689804
[TBL] [Abstract][Full Text] [Related]
12. Comparison of Dynamic Contrast-Enhanced MRI and Non-Mono-Exponential Model-Based Diffusion-Weighted Imaging for the Prediction of Prognostic Biomarkers and Molecular Subtypes of Breast Cancer Based on Radiomics.
Zhang L; Zhou XX; Liu L; Liu AY; Zhao WJ; Zhang HX; Zhu YM; Kuai ZX
J Magn Reson Imaging; 2023 Nov; 58(5):1590-1602. PubMed ID: 36661350
[TBL] [Abstract][Full Text] [Related]
13. Preoperative Assessment of MRI-Invisible Early-Stage Endometrial Cancer With MRI-Based Radiomics Analysis.
Jiang X; Song J; Zhang A; Cheng W; Duan S; Liu X; Chen T
J Magn Reson Imaging; 2023 Jul; 58(1):247-255. PubMed ID: 36259352
[TBL] [Abstract][Full Text] [Related]
14. Pretreatment Multiparametric MRI-Based Radiomics Analysis for the Diagnosis of Breast Phyllodes Tumors.
Ma X; Gong J; Hu F; Tang W; Gu Y; Peng W
J Magn Reson Imaging; 2023 Feb; 57(2):633-645. PubMed ID: 35657093
[TBL] [Abstract][Full Text] [Related]
15. Development and external validation of a multiparametric MRI-based radiomics model for preoperative prediction of microsatellite instability status in rectal cancer: a retrospective multicenter study.
Li Z; Zhang J; Zhong Q; Feng Z; Shi Y; Xu L; Zhang R; Yu F; Lv B; Yang T; Huang C; Cui F; Chen F
Eur Radiol; 2023 Mar; 33(3):1835-1843. PubMed ID: 36282309
[TBL] [Abstract][Full Text] [Related]
16. Glioblastoma and Solitary Brain Metastasis: Differentiation by Integrating Demographic-MRI and Deep-Learning Radiomics Signatures.
Zhang Y; Zhang H; Zhang H; Ouyang Y; Su R; Yang W; Huang B
J Magn Reson Imaging; 2023 Nov; ():. PubMed ID: 37955154
[TBL] [Abstract][Full Text] [Related]
17. Multiparametric-MRI-Based Radiomics Model for Differentiating Primary Central Nervous System Lymphoma From Glioblastoma: Development and Cross-Vendor Validation.
Xia W; Hu B; Li H; Geng C; Wu Q; Yang L; Yin B; Gao X; Li Y; Geng D
J Magn Reson Imaging; 2021 Jan; 53(1):242-250. PubMed ID: 32864825
[TBL] [Abstract][Full Text] [Related]
18. Evaluating Upstaging in Ductal Carcinoma In Situ Using Preoperative MRI-Based Radiomics.
Hong M; Fan S; Yu Z; Gao C; Fang Z; Du L; Wang S; Chen X; Xu M; Zhou C
J Magn Reson Imaging; 2023 Aug; 58(2):454-463. PubMed ID: 36440711
[TBL] [Abstract][Full Text] [Related]
19. Multiparametric MR Imaging Radiomics Signatures for Assessing the Recurrence Risk of ER+/HER2- Breast Cancer Quantified With 21-Gene Recurrence Score.
Chen Y; Tang W; Liu W; Li R; Wang Q; Shen X; Gong J; Gu Y; Peng W
J Magn Reson Imaging; 2023 Aug; 58(2):444-453. PubMed ID: 36440706
[TBL] [Abstract][Full Text] [Related]
20. Multimodality MRI radiomics analysis of TP53 mutations in triple negative breast cancer.
Sun K; Zhu H; Chai W; Yan F
Front Oncol; 2023; 13():1153261. PubMed ID: 37064157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
